RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
RETA
Delisted
RETA was delisted on the 25th of September, 2023.
43 hedge funds and large institutions have $146M invested in Reata Pharmaceuticals, Inc. Class A Common Stock in 2016 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 18 increasing their positions, 11 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
2% more funds holding
Funds holding: 42 → 43 (+1)
Holders
43
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$2.1M | |
| 2 | +$1.93M | |
| 3 | +$1.39M | |
| 4 |
EMFAT
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
|
+$1.24M |
| 5 |
OWD
Osborn Williams & Donohoe
Cincinnati,
Ohio
|
+$1.24M |
Top Sellers
| 1 | -$2.7M | |
| 2 | -$1.87M | |
| 3 | -$1.23M | |
| 4 |
SIM
Spark Investment Management
New York
|
-$677K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$413K |